Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2026-02-23 @ 11:34 AM
Study NCT ID:
NCT04338659
Status:
COMPLETED
Last Update Posted:
2023-10-10
First Post:
2020-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization: